Insider · CIK 0001903716
Esther Rajavelu
Files at SPRO (Spero Therapeutics, Inc.). First filing Nov 12, 2024, latest Nov 12, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SPRO: Spero Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | SPROsell Spero Therapeutics, Inc. | $95k 40,270 shares | -4% | +339% from low-19% from high | |
| 29Weak | SPROsell Spero Therapeutics, Inc. | $53k 40,596 shares | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | SPRO Spero Therapeutics, Inc. | SOpen-market sale Common Stock | -40,270 | $2.37 | $95k | 869,450 | Nov 12, 2025 |
| May 2, 2025 | SPRO Spero Therapeutics, Inc. | AGrant or award Common Stock | +185,000 | $0.00 | $0 | 909,720 | May 6, 2025 |
| Nov 7, 2024 | SPRO Spero Therapeutics, Inc. | SOpen-market sale Common Stock | -23,351 | $1.31 | $31k | 396,515 | Nov 12, 2024 |
| Nov 8, 2024 | SPRO Spero Therapeutics, Inc. | SOpen-market sale Common Stock | -17,245 | $1.30 | $22k | 379,270 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.